Taken together, these data, including our own results, suggest that the inactivation of p16INK4A/p14ARF locus in these carcinomas is rare and that in contrast, the upregulation of these genes could be associated with thyroid cancer progression. This evidence concerns the gene CDKN2A and thyroid cancer.